glp-1 for bulimia GLP-1s and Eating Disorders: Managing Food Noise & Recovery Safety Neurobiological Mechanisms and Therapeutic Potential

This study joins the ranks of previous publications demonstrating the potential neuroprotective effect of GLP-1 receptor agonists in glaucoma and suggests a need for further prospective trials

Glutathione c tm thy trong tt c cc t bo ng vt v ng vai tr quan trng trong nhiu chc nng c th

In November 2025, Novo Nordisk cut the price of Wegovy injectables, in 0.25 mg and 0.5 mg doses, offering a limited-time price of $199 per month for the first two months for those without insurance until March 2026

You may be a good candidate for GLP-1 treatment if you: Have been diagnosed with type 2 diabetes Have obesity, or a body mass index (BMI) of 30 or higher Have overweight (a BMI of 25 to 29.9) plus at least one weight-related condition, such as heart disease or type 2 diabetes Ultimately, the decision to start treatment for weight loss is up to you and your healthcare provider

The major symptoms are as follows: Chest discomfort or chest pain